본문 바로가기

Data Plus(+)

All 807,818 Page 6,223/80,782

검색

Contents

No Journal_name Subject Date DOI Author
745598 FRONTIERS IN IMMUNOLOGY Characterization of a Cohort of Patients With LIG4 Deficiency Reveals the Founder Effect of p.R278L, Unique to the Chinese Population 2021-09-24 10.3389/fimmu.2021.695993 Luo Xianze, Liu Qing, Jiang Jinqiu, Tang Wenjing, Ding Yuan, Zhou Lina, Yu Jie, Tang Xuemei, An Yunfei, Zhao Xiaodong
745597 FRONTIERS IN IMMUNOLOGY Corrigendum: CX3CR1 But Not CCR2 Expression Is Required for the Development of Autoimmune Peripheral Neuropathy in Mice 2021-09-24 10.3389/fimmu.2021.765892 Oladiran Oladayo, Shi Xiang Qun, Fournier Sylvie, Zhang Ji
745596 FRONTIERS IN IMMUNOLOGY N6-Methyladenosine and Rheumatoid Arthritis: A Comprehensive Review 2021-09-24 10.3389/fimmu.2021.731842 Wu Sha, Li Xiao-Feng, Wu Yuan-Yuan, Yin Su-Qin, Huang Cheng, Li Jun
745595 FRONTIERS IN IMMUNOLOGY Isolation of Skin Leukocytes Uncovers Phagocyte Inflammatory Responses During Induction and Resolution of Cutaneous Inflammation in Fish 2021-09-24 10.3389/fimmu.2021.725063 Soliman Amro M., Yoon Taekwan, Wang Jiahui, Stafford James L., Barreda Daniel R.
745594 FRONTIERS IN IMMUNOLOGY Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients 2021-09-24 10.3389/fimmu.2021.749094 Davis Joanne E., Du Kelei, Ludford-Menting Mandy J., Prabahran Ashvind, Wong Eric, Huntington Nicholas D., Koldej Rachel M., Ritchie David S.
745593 FRONTIERS IN IMMUNOLOGY Comutations in DDR Pathways Predict Atezolizumab Response in Non-Small Cell Lung Cancer Patients 2021-09-24 10.3389/fimmu.2021.708558 Xiong Anning, Nie Wei, Zhou Yan, Li Changhui, Gu Kai, Zhang Ding, Chen Shiqing, Wen Fengcai, Zhong Hua, Han Baohui, Zhang Xueyan
745592 FRONTIERS IN IMMUNOLOGY Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol 2021-09-24 10.3389/fimmu.2021.753319 Sablerolles Roos S. G., Goorhuis Abraham, GeurtsvanKessel Corine H., de Vries Rory D., Huckriede Anke L. W., Koopmans Marion P. G., Lafeber Melvin, Postma Douwe F., van Baarle Debbie, Visser Leo G., Dalm Virgil A. S. H., Kootstra Neeltje A., Rietdijk Wim J. R., van der Kuy P. Hugo M.
745591 FRONTIERS IN IMMUNOLOGY α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants 2021-09-24 10.3389/fimmu.2021.757691 Zou Jintao, Jing Haiming, Zhang Xiaoli, Liu Yiheng, Zhao Zhuo, Duan Lianli, Yuan Yue, Chen Zhifu, Gou Qiang, Xiong Qingshan, Li Sisi, Yang Feng, Zeng Hao, Zou Quanming, Zhang Jinyong
745590 FRONTIERS IN IMMUNOLOGY Low Soluble Programmed Cell Death Protein 1 Levels After Allogeneic Stem Cell Transplantation Predict Moderate or Severe Chronic GvHD and Inferior Overall Survival 2021-09-24 10.3389/fimmu.2021.694843 Kordelas Lambros, Buttkereit Ulrike, Heinemann Falko M., Horn Peter A., Giebel Bernd, Beelen Dietrich W., Reinhardt H. Christian, Rebmann Vera
745589 FRONTIERS IN IMMUNOLOGY Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response 2021-09-24 10.3389/fimmu.2021.738481 Palmroth Maaria, Kuuliala Krista, Peltomaa Ritva, Virtanen Anniina, Kuuliala Antti, Kurttila Antti, Kinnunen Anna, Leirisalo-Repo Marjatta, Silvennoinen Olli, Isomäki Pia